Literature DB >> 11714732

Out, damned dot: studies of the NADPH oxidase in atherosclerosis.

K K Griendling1, D G Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714732      PMCID: PMC209430          DOI: 10.1172/JCI14453

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control.

Authors:  H P Souza; F R Laurindo; R C Ziegelstein; C O Berlowitz; J L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

2.  p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.

Authors:  P A Barry-Lane; C Patterson; M van der Merwe; Z Hu; S M Holland; E T Yeh; M S Runge
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.

Authors:  T J Guzik; N E West; E Black; D McDonald; C Ratnatunga; R Pillai; K M Channon
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

4.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

Authors:  N G Stephens; A Parsons; P M Schofield; F Kelly; K Cheeseman; M J Mitchinson
Journal:  Lancet       Date:  1996-03-23       Impact factor: 79.321

5.  Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice.

Authors:  E A Kirk; M C Dinauer; H Rosen; A Chait; J W Heinecke; R C LeBoeuf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

6.  Vascular effects following homozygous disruption of p47(phox) : An essential component of NADPH oxidase.

Authors:  E Hsich; B H Segal; P J Pagano; F E Rey; B Paigen; J Deleonardis; R F Hoyt; S M Holland; T Finkel
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

  6 in total
  15 in total

1.  Attenuation of the development of hypercholesterolemic atherosclerosis by thymoquinone.

Authors:  Ahmed Ragheb; Fawzy Elbarbry; Kailash Prasad; Adel Mohamed; Mohamed S Ahmed; Ahmed Shoker
Journal:  Int J Angiol       Date:  2008

Review 2.  Contribution of mitochondrial oxidative stress to hypertension.

Authors:  Sergey I Dikalov; Anna E Dikalova
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-03       Impact factor: 2.894

3.  Crosstalk Between Mitochondrial Hyperacetylation and Oxidative Stress in Vascular Dysfunction and Hypertension.

Authors:  Sergey I Dikalov; Anna E Dikalova
Journal:  Antioxid Redox Signal       Date:  2019-02-28       Impact factor: 8.401

Review 4.  Oxidative stress in obstructive nephropathy.

Authors:  Amélie Dendooven; David A Ishola; Tri Q Nguyen; Dionne M Van der Giezen; Robbert Jan Kok; Roel Goldschmeding; Jaap A Joles
Journal:  Int J Exp Pathol       Date:  2010-08-27       Impact factor: 1.925

Review 5.  Role of mitochondrial oxidative stress in hypertension.

Authors:  Sergey I Dikalov; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

6.  Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo.

Authors:  Yunzhou Dong; Miao Zhang; Shuangxi Wang; Bin Liang; Zhengxing Zhao; Chao Liu; Mingyuan Wu; Hyoung Chul Choi; Timothy J Lyons; Ming-Hui Zou
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

7.  Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Tzong-Shyuan Lee; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

Review 8.  Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

Authors:  Ulrich Laufs
Journal:  Eur J Clin Pharmacol       Date:  2003-02-18       Impact factor: 2.953

9.  Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.

Authors:  Anna Dikalova; Vladimir Mayorov; Liang Xiao; Alexander Panov; Venkataraman Amarnath; Irene Zagol-Ikapitte; Aurelia Vergeade; Mingfang Ao; Valery Yermalitsky; Rafal R Nazarewicz; Olivier Boutaud; Marcos G Lopez; Frederic T Billings; Sean Davies; L Jackson Roberts; David G Harrison; Sergey Dikalov
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

10.  Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Yao-Ping Lin; Ching-Fang Tang; Tzong-Shyuan Lee; Chih-Pei Lin; Der-Cherng Tarng
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.